Adenosine A2B receptor agonist improves epidermal barrier integrity in a murine model of epidermal hyperplasia
Open Access
- 8 March 2024
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 173, 116401
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund
- Ministerio de Ciencia, Innovación y Universidades (PID2021-124890OB-I00)
- Ministerio de Ciencia, Innovación y Universidades (SAF2017-85806-R)
- Ministerio de Ciencia e Innovación
- European Commission
- Agencia Estatal de Investigación
This publication has 60 references indexed in Scilit:
- The possible role of the nucleoside adenosine in countering skin aging: A reviewBioFactors, 2022
- The adenosine A2B G protein-coupled receptor: Recent advances and therapeutic implicationsPharmacology & Therapeutics, 2019
- Adenosine signaling and the immune system: When a lot could be too muchImmunology Letters, 2019
- Canonical and non-canonical adenosinergic pathwaysImmunology Letters, 2019
- Research Techniques Made Simple: Murine Models of Human PsoriasisJournal of Investigative Dermatology, 2018
- Adenosine A2A and A2B Receptors Differentially Modulate Keratinocyte Proliferation: Possible Deregulation in Psoriatic EpidermisJournal of Investigative Dermatology, 2017
- Promotion of Wound Healing by an Agonist of Adenosine A2A Receptor Is Dependent on Tissue Plasminogen ActivatorInflammation, 2015
- Regulation of Involucrin in Psoriatic Epidermal Keratinocytes: The Roles of ERK1/2 and GSK-3βCell Biochemistry and Biophysics, 2013
- Structure and function of the epidermis related to barrier propertiesClinics in Dermatology, 2012
- Adenosine: an endogenous regulator of innate immunityTrends in Immunology, 2004